BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 33198810)

  • 21. Vision loss following high-dose proton-based radiotherapy for skull-base chordoma and chondrosarcoma.
    De Leo AN; Holtzman AL; Ho MW; Morris CG; Rutenberg MS; Rotondo RL; Bates JE; Indelicato DJ; Rao D; Asa Hasan M; Mendenhall WM
    Radiother Oncol; 2021 May; 158():125-130. PubMed ID: 33610625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dosimetric benefits of robust treatment planning for intensity modulated proton therapy for base-of-skull cancers.
    Liu W; Mohan R; Park P; Liu Z; Li H; Li X; Li Y; Wu R; Sahoo N; Dong L; Zhu XR; Grosshans DR
    Pract Radiat Oncol; 2014; 4(6):384-91. PubMed ID: 25407859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypothalamic/pituitary function following high-dose conformal radiotherapy to the base of skull: demonstration of a dose-effect relationship using dose-volume histogram analysis.
    Pai HH; Thornton A; Katznelson L; Finkelstein DM; Adams JA; Fullerton BC; Loeffler JS; Leibsch NJ; Klibanski A; Munzenrider JE
    Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):1079-92. PubMed ID: 11240250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypofractionated stereotactic radiation therapy for skull base and upper cervical chordoma and chondrosarcoma: preliminary results.
    Gwak HS; Yoo HJ; Youn SM; Chang U; Lee DH; Yoo SY; Rhee CH
    Stereotact Funct Neurosurg; 2005; 83(5-6):233-43. PubMed ID: 16601376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-dose radiotherapy in the management of chordoma and chondrosarcoma of the skull base and cervical spine: Part 1--Clinical outcomes.
    Foweraker KL; Burton KE; Maynard SE; Jena R; Jefferies SJ; Laing RJ; Burnet NG
    Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):509-16. PubMed ID: 17524633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Prospective Outcomes Study of Proton Therapy for Chordomas and Chondrosarcomas of the Spine.
    Indelicato DJ; Rotondo RL; Begosh-Mayne D; Scarborough MT; Gibbs CP; Morris CG; Mendenhall WM
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):297-303. PubMed ID: 27084648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proton beam therapy for skull base chordomas in 106 patients: A dose adaptive radiation protocol.
    Fung V; Calugaru V; Bolle S; Mammar H; Alapetite C; Maingon P; De Marzi L; Froelich S; Habrand JL; Dendale R; Noël G; Feuvret L
    Radiother Oncol; 2018 Aug; 128(2):198-202. PubMed ID: 29310903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prospective clinical trial of proton therapy for chordoma and chondrosarcoma: Feasibility assessment.
    Baumann BC; Lustig RA; Mazzoni S; Grady SM; O'Malley BW; Lee JYK; Newman JG; Schuster JM; Both S; Lin A; Dorsey JF; Alonso-Basanta M
    J Surg Oncol; 2019 Aug; 120(2):200-205. PubMed ID: 31111502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proton and carbon ion radiotherapy in skull base chordomas: a prospective study based on a dual particle and a patient-customized treatment strategy.
    Iannalfi A; D'Ippolito E; Riva G; Molinelli S; Gandini S; Viselner G; Fiore MR; Vischioni B; Vitolo V; Bonora M; Ronchi S; Petrucci R; Barcellini A; Mirandola A; Russo S; Vai A; Mastella E; Magro G; Maestri D; Ciocca M; Preda L; Valvo F; Orecchia R
    Neuro Oncol; 2020 Sep; 22(9):1348-1358. PubMed ID: 32193546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Radiation therapy for chordomas and chondrosarcomas of the base of the skull and cervical spine].
    Noël G; Jauffret E; Crevoisier RD; Habrand JL; Mammar H; Haie-Meder C; Hasboun D; Ferrand R; Boisserie G; Pontvert D; Beaudré A; Gaboriaud G; Mazal A; Guedea F; Petriz L; Mazeron JJ
    Bull Cancer; 2002; 89(7-8):713-23. PubMed ID: 12206985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The incidence of brainstem toxicity following high-dose conformal proton therapy for adult skull-base malignancies.
    Holtzman AL; Rutenberg MS; De Leo AN; Rao D; Patel J; Morris CG; Indelicato DJ; Mendenhall WM
    Acta Oncol; 2022 Aug; 61(8):1026-1031. PubMed ID: 35897132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proton beam radiotherapy: report of the first ten patients treated at the "Centro Nazionale di Adroterapia Oncologica (CNAO)" for skull base and spine tumours.
    Orecchia R; Vitolo V; Fiore MR; Fossati P; Iannalfi A; Vischioni B; Srivastava A; Tuan J; Ciocca M; Molinelli S; Mirandola A; Vilches G; Mairani A; Tagaste B; Riboldi M; Fontana G; Baroni G; Rossi S; Krengli M
    Radiol Med; 2014 Apr; 119(4):277-82. PubMed ID: 24337759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chordomas of the skull base: follow-up review and prognostic factors.
    Colli BO; Al-Mefty O
    Neurosurg Focus; 2001 Mar; 10(3):E1. PubMed ID: 16734401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chordomas of the skull base and cervical spine: clinical outcomes associated with a multimodal surgical resection combined with proton-beam radiation in 40 patients.
    Yasuda M; Bresson D; Chibbaro S; Cornelius JF; Polivka M; Feuvret L; Takayasu M; George B
    Neurosurg Rev; 2012 Apr; 35(2):171-82; discussion 182-3. PubMed ID: 21863225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Skull base chordoma and chondrosarcoma: influence of clinical and demographic factors on prognosis: a SEER analysis.
    Bohman LE; Koch M; Bailey RL; Alonso-Basanta M; Lee JY
    World Neurosurg; 2014 Nov; 82(5):806-14. PubMed ID: 25009165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single-institution clinical experience using robust intensity modulated proton therapy in chordoma and chondrosarcoma of the mobile spine and sacrum: Feasibility and need for plan adaptation.
    Kroesen M; Miladinovic V; Hutschemaekers SAJ; Jacobs J; van der Vos C; Wolf AL; Hoogeman MS; van Vulpen M; Bloem JL; P D S Dijkstra S; Peul WC; Penninkhof JJ; Krol ADG
    Radiother Oncol; 2022 Jan; 166():58-64. PubMed ID: 34843840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chordoma and chondrosarcoma: similar, but quite different, skull base tumors.
    Almefty K; Pravdenkova S; Colli BO; Al-Mefty O; Gokden M
    Cancer; 2007 Dec; 110(11):2457-67. PubMed ID: 17894390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A treatment planning comparison of combined photon-proton beams versus proton beams-only for the treatment of skull base tumors.
    Feuvret L; Noel G; Weber DC; Pommier P; Ferrand R; De Marzi L; Dhermain F; Alapetite C; Mammar H; Boisserie G; Habrand JL; Mazeron JJ
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):944-54. PubMed ID: 17889276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proton radiotherapy in management of pediatric base of skull tumors.
    Hug EB; Sweeney RA; Nurre PM; Holloway KC; Slater JD; Munzenrider JE
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):1017-24. PubMed ID: 11958897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic impact of the "Sekhar grading system for cranial Chordomas" in patients treated with pencil beam scanning proton therapy: an institutional analysis.
    Hottinger AL; Bojaxhiu B; Ahlhelm F; Walser M; Bachtiary B; Zepter S; Lomax T; Pica A; Weber DC
    Radiat Oncol; 2020 May; 15(1):96. PubMed ID: 32375820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.